196 related articles for article (PubMed ID: 23623071)
1. Accelerating protein release from microparticles for regenerative medicine applications.
White LJ; Kirby GT; Cox HC; Qodratnama R; Qutachi O; Rose FR; Shakesheff KM
Mater Sci Eng C Mater Biol Appl; 2013 Jul; 33(5):2578-83. PubMed ID: 23623071
[TBL] [Abstract][Full Text] [Related]
2. Biodegradable triblock copolymer microspheres based on thermosensitive sol-gel transition.
Kwon YM; Kim SW
Pharm Res; 2004 Feb; 21(2):339-43. PubMed ID: 15032317
[TBL] [Abstract][Full Text] [Related]
3. Controlled release of NFkappaB decoy oligonucleotides from biodegradable polymer microparticles.
Zhu X; Lu L; Currier BL; Windebank AJ; Yaszemski MJ
Biomaterials; 2002 Jul; 23(13):2683-92. PubMed ID: 12059017
[TBL] [Abstract][Full Text] [Related]
4. PLGA-PEG microspheres of teverelix: influence of polymer type on microsphere characteristics and on teverelix in vitro release.
Mallardé D; Boutignon F; Moine F; Barré E; David S; Touchet H; Ferruti P; Deghenghi R
Int J Pharm; 2003 Aug; 261(1-2):69-80. PubMed ID: 12878396
[TBL] [Abstract][Full Text] [Related]
5. Stability of bovine serum albumin complexed with PEG-poly(L-histidine) diblock copolymer in PLGA microspheres.
Kim JH; Taluja A; Knutson K; Han Bae Y
J Control Release; 2005 Dec; 109(1-3):86-100. PubMed ID: 16266769
[TBL] [Abstract][Full Text] [Related]
6. Modification of biodegradable poly(malate) and poly(lactic-co-glycolic acid) microparticles with low molecular polyethylene glycol.
Yoncheva K; Lambov N; Miloshev S
Drug Dev Ind Pharm; 2009 Apr; 35(4):449-54. PubMed ID: 19288298
[TBL] [Abstract][Full Text] [Related]
7. Controlled release of GAG-binding enhanced transduction (GET) peptides for sustained and highly efficient intracellular delivery.
Abu-Awwad HAM; Thiagarajan L; Dixon JE
Acta Biomater; 2017 Jul; 57():225-237. PubMed ID: 28457961
[TBL] [Abstract][Full Text] [Related]
8. Formulations for modulation of protein release from large-size PLGA microparticles for tissue engineering.
Qodratnama R; Serino LP; Cox HC; Qutachi O; White LJ
Mater Sci Eng C Mater Biol Appl; 2015 Feb; 47():230-6. PubMed ID: 25492193
[TBL] [Abstract][Full Text] [Related]
9. In vitro drug release behavior, mechanism and antimicrobial activity of rifampicin loaded low molecular weight PLGA-PEG-PLGA triblock copolymeric nanospheres.
Gajendiran M; Divakar S; Raaman N; Balasubramanian S
Curr Drug Deliv; 2013 Dec; 10(6):722-31. PubMed ID: 23701139
[TBL] [Abstract][Full Text] [Related]
10. Controlled release of transforming growth factor beta1 from biodegradable polymer microparticles.
Lu L; Stamatas GN; Mikos AG
J Biomed Mater Res; 2000 Jun; 50(3):440-51. PubMed ID: 10737887
[TBL] [Abstract][Full Text] [Related]
11. Comparative degradation study of biodegradable microspheres of poly(DL-lactide-co-glycolide) with poly(ethyleneglycol) derivates.
Garcia JT; Fariña JB; Munguía O; Llabrés M
J Microencapsul; 1999; 16(1):83-94. PubMed ID: 9972505
[TBL] [Abstract][Full Text] [Related]
12. Influence of the microencapsulation method and peptide loading on poly(lactic acid) and poly(lactic-co-glycolic acid) degradation during in vitro testing.
Witschi C; Doelker E
J Control Release; 1998 Feb; 51(2-3):327-41. PubMed ID: 9685930
[TBL] [Abstract][Full Text] [Related]
13. Why does PEG 400 co-encapsulation improve NGF stability and release from PLGA biodegradable microspheres?
Péan JM; Boury F; Venier-Julienne MC; Menei P; Proust JE; Benoit JP
Pharm Res; 1999 Aug; 16(8):1294-9. PubMed ID: 10468034
[TBL] [Abstract][Full Text] [Related]
14. Design and development of a novel controlled release PLGA alginate-pectinate polyspheric drug delivery system.
Sweet JL; Pillay V; Choonara YE
Drug Deliv; 2007 Jul; 14(5):309-18. PubMed ID: 17613019
[TBL] [Abstract][Full Text] [Related]
15. Development and evaluation of sustained-release clonidine-loaded PLGA microparticles.
Gaignaux A; Réeff J; Siepmann F; Siepmann J; De Vriese C; Goole J; Amighi K
Int J Pharm; 2012 Nov; 437(1-2):20-8. PubMed ID: 22903047
[TBL] [Abstract][Full Text] [Related]
16. Effect of formulation parameters on 2-methoxyestradiol release from injectable cylindrical poly(DL-lactide-co-glycolide) implants.
Desai KG; Mallery SR; Schwendeman SP
Eur J Pharm Biopharm; 2008 Sep; 70(1):187-98. PubMed ID: 18472254
[TBL] [Abstract][Full Text] [Related]
17. Self-assembled nanomicelles using PLGA-PEG amphiphilic block copolymer for insulin delivery: a physicochemical investigation and determination of CMC values.
Ashjari M; Khoee S; Mahdavian AR; Rahmatolahzadeh R
J Mater Sci Mater Med; 2012 Apr; 23(4):943-53. PubMed ID: 22354326
[TBL] [Abstract][Full Text] [Related]
18. Controlled delivery of ganciclovir to the retina with drug-loaded Poly(d,L-lactide-co-glycolide) (PLGA) microspheres dispersed in PLGA-PEG-PLGA Gel: a novel intravitreal delivery system for the treatment of cytomegalovirus retinitis.
Duvvuri S; Janoria KG; Pal D; Mitra AK
J Ocul Pharmacol Ther; 2007 Jun; 23(3):264-74. PubMed ID: 17593010
[TBL] [Abstract][Full Text] [Related]
19. The influence of covalently linked and free polyethylene glycol on the structural and release properties of rhBMP-2 loaded microspheres.
Lochmann A; Nitzsche H; von Einem S; Schwarz E; Mäder K
J Control Release; 2010 Oct; 147(1):92-100. PubMed ID: 20603166
[TBL] [Abstract][Full Text] [Related]
20. 5-Fluorouracil encapsulated HA/PLGA composite microspheres for cancer therapy.
Lin Y; Li Y; Ooi CP
J Mater Sci Mater Med; 2012 Oct; 23(10):2453-60. PubMed ID: 22843166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]